Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Pupa, Serenella M."'
Autor:
Ciravolo V; Molecular Targeting Unit, Department of Experimental Oncology and Molecular Medicine, Fondazione IRCCS, Istituto Nazionale Tumori, Milan, Italy., Huber V, Ghedini GC, Venturelli E, Bianchi F, Campiglio M, Morelli D, Villa A, Della Mina P, Menard S, Filipazzi P, Rivoltini L, Tagliabue E, Pupa SM
Publikováno v:
Journal of cellular physiology [J Cell Physiol] 2012 Feb; Vol. 227 (2), pp. 658-67.
Autor:
Biunno I; Istituto di Tecnologie Biomediche, CNR, Segrate-Milano, Italy., Cattaneo M, Orlandi R, Canton C, Biagiotti L, Ferrero S, Barberis M, Pupa SM, Scarpa A, Ménard S
Publikováno v:
Journal of cellular physiology [J Cell Physiol] 2006 Jul; Vol. 208 (1), pp. 23-38.
Autor:
Forti S; Department of Experimental Oncology, Istituto Nazionale Tumori, Milano, Italy., Scanlan MJ, Invernizzi A, Castiglioni F, Pupa S, Agresti R, Fontanelli R, Morelli D, Old LJ, Pupa SM, Ménard S
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2002 Jun; Vol. 73 (3), pp. 245-56.
Autor:
Rossella Canese, Elda Tagliabue, Patrizia Nanni, Egidio Iorio, Daniele Morelli, Massimo Di Nicola, Simona Faraci, Patrizia Casalini, Lorenzo Castagnoli, Matteo Dugo, Claudio Vernieri, Ada Koschorke, Serenella M. Pupa
Publikováno v:
Journal of Cellular Physiology
Despite different molecular tumor profiles indicate that human epidermal growth factor receptor 2 (HER2) messenger RNA (mRNA) levels mirror HER2 addiction and trastuzumab benefit in HER2-positive breast cancer (BC), the identification of noninvasive